A reduced insulin sensitivity, attributable to a post-receptor binding defect with an alteration in the gene expression of some genes involved in insulin signaling pathways, has also been identified as an intrinsic component of PCOS, regardless of obesity presence [29–31]. This evidence concerns the gene INS and polycystic ovary syndrome.